Strategic Growth Insights on Cosentix and Kiskali

This chapter explores the strategic opportunities of the psoriasis drug Cosentix, focusing on its performance and growth potential in the U.S. and China. It also examines the success of Kiskali in the breast cancer market and how its acceptance has positively affected the company's earnings outlook.